Evaluation of particulate acellular vaccines against Brucella ovis infection in rams

Vaccine

Volumn 28, Issue 17, 2010, Pages 3038-3046

  Da Costa Martins, Raquel ^a   Irache, Juan M ^a   Blasco, José M ^b   Muñoz, M Pilar ^b   Marín, Clara M ^b   Jesus Grillo M ^b   Jesus De Miguel M ^b   Barberán, Montserrat ^b   Gamazo, Carlos ^a  

^a Immunoadjuvant unit   (Spain)

^b Agrifood Institute of Aragón IA2   (Spain)

Author keywords

Adjuvant; Brucellosis; Microparticle; Nanoparticle; Ram; Vaccine

Indexed keywords

ACELLULAR VACCINE; BRUCELLA VACCINE; NANOPARTICLE; OUTER MEMBRANE PROTEIN; POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRUCELLA OVIS; BRUCELLOSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; MALE; NONHUMAN; PRIORITY JOURNAL; RAM (SHEEP); SINGLE DRUG DOSE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRUCELLA OVIS; BRUCELLA VACCINE; BRUCELLOSIS; DRUG CARRIERS; FEMALE; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; NANOPARTICLES; PREGNANCY; SHEEP DISEASES; VACCINATION; VACCINES, ACELLULAR;

EID: 77949654868     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.073     Document Type: Article

References (42)

1. Boschiroli M.L., Foulongne V., and O'Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol 4 1 (2001) 58-64
2. Blasco J.M. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 31 3-4 (1997) 275-283
3. Blasco J.M., and Diaz R. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 342 8874 (1993) 805
4. Murillo M., Grillo M.J., Rene J., Marin C.M., Barberan M., Goni M.M., et al. A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice. Vaccine 19 30 (2001) 4099-4106
5. Munoz P.M., Estevan M., Marin C.M., Jesus De Miguel M., Jesus Grillo M., Barberan M., et al. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. Vaccine 24 11 (2006) 1897-1905
6. Ochoa J., Irache J.M., Tamayo I., Walz A., DelVecchio V.G., and Gamazo C. Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice. Vaccine 25 22 (2007) 4410-4419
7. Salman H.H., Irache J.M., and Gamazo C. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine (2009)
8. Gomez S., Gamazo C., San Roman B., Grau A., Espuelas S., Ferrer M., et al. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne. J Immunol Methods (2009)
9. Gamazo C., Winter A.J., Moriyon I., Riezu-Boj J.I., Blasco J.M., and Diaz R. Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun 57 5 (1989) 1419-1426
10. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 1 (1985) 76-85
11. Osborn M.J. Studies on the Gram-negative cell wall. I. Evidence for the role of 2-keto-3-deoxyoctonate in the lipopolysaccharide of Salmonella typhimurium. Proc Natl Acad Sci USA 50 (1963) 499-506
12. Blasco J.M., Gamazo C., Winter A.J., Jimenez de Bagues M.P., Marin C., Barberan M., et al. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Vet Immunol Immunopathol 37 3-4 (1993) 257-270
13. Marin C.M., Jimenez de Bagues M.P., Blasco J.M., Gamazo C., Moriyon I., and Diaz R. Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts. Vet Rec 125 20 (1989) 504-508
14. Da Costa Martins R., Gamazo C., and Irache J.M. Design and influence of gamma-irradiation on the biopharmaceutical properties of nanoparticles containing an antigenic complex from Brucella ovis. Eur J Pharm Sci 37 5 (2009) 563-572
15. Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., and Couvreur P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm Res 17 6 (2000) 707-714
16. Arbos P., Wirth M., Arangoa M.A., Gabor F., Irache J.M., and Gantrez. AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J Control Release 83 3 (2002) 321-330
17. Benson J.R., and Hare P.E. O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin. Proc Natl Acad Sci USA 72 2 (1975) 619-622
18. Estevan M., Gamazo C., Grillo M.J., Del Barrio G.G., Blasco J.M., and Irache J.M. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice. Vaccine 24 19 (2006) 4179-4187
19. Marin C.M., Jimenez de Bagues M.P., Barberan M., and Blasco J.M. Comparison of two selective media for the isolation of Brucella melitensis from naturally infected sheep and goats. Vet Rec 138 17 (1996) 409-411
20. Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory. INRA; 1988.
21. Blasco J.M., Garin-Bastuji B., Marin C.M., Gerbier G., Fanlo J., Jimenez de Bagues M.P., et al. Efficacy of different Rose Bengal and complement fixation antigens for the diagnosis of Brucella melitensis infection in sheep and goats. Vet Rec 134 16 (1994) 415-420
22. Marin C.M., Alonso-Urmeneta B., Moriyon I., Perez-Gomez S., and Blasco J.M. Comparison of polyclonal, monoclonal and protein G peroxidase conjugates in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis in sheep. Vet Rec 143 14 (1998) 390-394
23. Riezu-Boj J.I., Moriyon I., Blasco J.M., Gamazo C., and Diaz R. Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis. Infect Immun 58 2 (1990) 489-494
24. Gomez S., Gamazo C., Roman B.S., Ferrer M., Sanz M.L., Irache J.M., et al. Nanoparticles as an adjuvant for oral immunotherapy with allergens. Vaccine 25 29 (2007) 5263-5271
25. Irache J.M., Salman H.H., Gamazo C., and Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 5 6 (2008) 703-724
26. Salman H.H., Gamazo C., Campanero M.A., and Irache J.M. Bioadhesive mannosylated nanoparticles for oral drug delivery. J Nanosci Nanotechnol 6 9-10 (2006) 3203-3209
27. Figdor C.G., van Kooyk Y., and Adema G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2 2 (2002) 77-84
28. Keler T., Ramakrishna V., and Fanger M.W. Mannose receptor-targeted vaccines. Expert Opin Biol Ther 4 12 (2004) 1953-1962
29. Ramakrishna V., Vasilakos J.P., Tario Jr. J.D., Berger M.A., Wallace P.K., and Keler T. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells. J Transl Med 5 (2007) 5
30. Jain S., and Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res 16 4 (2006) 331-345
31. Jain S.K., Gupta Y., Jain A., Saxena A.R., Khare P., and Jain A. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine 4 1 (2008) 41-48
32. Underhill D.M., and Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 20 (2002) 825-852
33. Grazia Cappiello M., Sutterwala F.S., Trinchieri G., Mosser D.M., and Ma X. Suppression of IL-12 transcription in macrophages following Fc gamma receptor ligation. J Immunol 166 7 (2001) 4498-4506
34. Dacosta B., Ryter A., Mounier J., and Sansonetti P. Immunodetection of lipopolysaccharide in macrophages during the processing of non invasive Shigella dysenteriae. Biol Cell 69 3 (1990) 171-178
35. Lapaque N., Forquet F., de Chastellier C., Mishal Z., Jolly G., Moreno E., et al. Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts. Cell Microbiol 8 2 (2006) 197-206
36. Forestier C., Deleuil F., Lapaque N., Moreno E., and Gorvel J.P. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol 165 9 (2000) 5202-5210
37. Tokita D., Shishida M., Ohdan H., Onoe T., Hara H., Tanaka Y., et al. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity. J Immunol 177 6 (2006) 3615-3624
38. He J.Q., Wiesmann C., and van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol 45 16 (2008) 4041-4047
39. Ogawara K., Yoshida M., Takakura Y., Hashida M., Higaki K., and Kimura T. Interaction of polystyrene microspheres with liver cells: roles of membrane receptors and serum proteins. Biochim Biophys Acta 1472 1-2 (1999) 165-172
40. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 1 (2003) 51-62
41. De Creus A., Abe M., Lau A.H., Hackstein H., Raimondi G., and Thomson A.W. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 174 4 (2005) 2037-2045
42. del Barrio G.G., Novo F.J., and Irache J.M. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties. J Control Release 86 1 (2003) 123-130